Louisiana families are fighting for awareness and recognition of a rare neurological condition that affects children.

Axsome Therapeutics said it's dopamine and norepinephrine reuptake inhibitor solriamfetol (Sunosi), approved for excessive ...

In his new book, No More Normal, psychiatrist Alastair Santhouse recalls an experience from the 1980s when he was a ...

In his new book, No More Normal, psychiatrist Alastair Santhouse recalls an experience from the 1980s when he was a ...

The mental disorders of psychosis and schizophrenia have always been discussed interchangeably even in the medical circles, ...

The mental disorders of psychosis and schizophrenia have always been discussed interchangeably even in the medical circles, ...

The Company reported a net loss of approximately $29.9 million, or $0.90 per share, for the fiscal year ended December 31, 2024, compared to a net loss of approximately $39.3 million, or $1.65 per ...

Researchers have developed a virtual reality-based system that shows promise in improving the differentiation between common ...

Researchers have developed a virtual reality-based system that shows promise in improving the differentiation between common mental health conditions, potentially paving the way for earlier and more ...

A recent study of the hoarding phenomenon within schizophrenia spectrum disorders highlights the need for nuanced assessments ...

BPD is characterized by extreme emotional dysregulation, whereas schizophrenia mainly involves a disconnect from reality ...

Joshua Kaufman, MD, of CDPHP, discusses the significance of long-acting injectables (LAIs) in improving adherence, reducing the risk of relapse, and preventing hospitalizations.